---
title: "AJJ Medtech FY2025 Annual Report: The Fundamentals Are Improving"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000596486.md"
description: "$AJJ Medtech(584.SG) AJJ Medtech (SGX: 584) is not only showing higher revenue and narrower losses in FY2025.Two points may matter more than they first appear:• continued support from major shareholders and..."
datetime: "2026-04-22T06:00:35.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000596486.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000596486.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000596486.md)
author: "[SG Visual Research](https://longbridge.com/en/profiles/24298178.md)"
generator: "portal-rs"
---

# AJJ Medtech FY2025 Annual Report: The Fundamentals Are Improving

$AJJ Medtech(584.SG)

AJJ Medtech (SGX: 584) is not only showing higher revenue and narrower losses in FY2025.  
Two points may matter more than they first appear:  
• continued support from major shareholders and management during the current scaling phase  
• growing certification and regulatory capabilities, which may become a real moat in healthcare

### Related Stocks

- [584.SG](https://longbridge.com/en/quote/584.SG.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**